Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00808665 · ClinicalTrials.gov registry record · Phase 4
Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion
A Phase 4 study of Spinal Stenosis and Spinal Diseases, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT00808665: Completed Phase 4 study of Spinal Stenosis and Spinal Diseases, sponsored by Vanderbilt University Medical Center.
NCT00808665 is a Phase 4 study of Spinal Stenosis and Spinal Diseases that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 68 participants, below the 545-participant average among 15 other Spinal Stenosis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00808665, a Phase 4 study of Spinal Stenosis and Spinal Diseases, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
Major lumbar spine surgery causes inflammation, soreness and swelling that can delay discharge from the hospital. Dexmedetomidine (DEX) has been shown to have anti-inflammatory effects. This study will evaluate whether DEX can help get patients out of the hospital faster after major spine surgery by reducing the inflammation associated with the procedure itself. A separate part of the study will evaluate the blood levels of some specific indicators of inflammation called cytokines. Measuring cytokines before and after surgery will aid in determining if DEX has altered the inflammatory response.
Conditions Studied
Interventions
- DRUG Dexmedetomidine
- DRUG 0.9% Saline
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
What the finished NCT00808665 record still lists
NCT00808665 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 545-participant average among 15 other Spinal Stenosis trials with a reported enrollment target (88% lower).
The record links to 4 conditions, with Spinal Stenosis appearing as the primary indexed condition, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT00808665 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00808665 about?
NCT00808665 is a clinical study titled "Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion". Major lumbar spine surgery causes inflammation, soreness and swelling that can delay discharge from the hospital. Dexmedetomidine (DEX) has been shown to have anti-inflammatory effects. This study will evaluate whether DEX can help get patients out of the hospital faster after major spine surgery by...
What is the current status of trial NCT00808665?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2009-06. Estimated completion is 2012-12.
What conditions does trial NCT00808665 study?
This clinical trial studies the following conditions: Spinal Stenosis, Spinal Diseases, Spinal Fusion Acquired, Lesions of Lumbosacral Intervertebral Disc.
What interventions are being tested in trial NCT00808665?
The interventions under investigation include: Dexmedetomidine (DRUG), 0.9% Saline (DRUG).
Who is sponsoring clinical trial NCT00808665?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00808665 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00808665's enrollment target sits among peer trials
68 9th of 15 higher than 7 of 15 other Spinal Stenosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia